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Cardiac resynchronization therapy (CRT) leads to beneficial left ventricular (LV) remodeling, 
restoration of dyssynchrony, and reduction in hospitalization and mortality in patients with 
heart failure (HF).1) Beyond the western countries, the CRT implantation rates are steadily 
increasing in Asian population.2) However, appropriate patient selection for CRT is an 
important goal as 30–40% patients do not experience the expected benefit.3)
Although several studies have been conducted to identify appropriate candidates for CRT 
based on sex differences, HF etiology, LV volume, and left atrial volume, the simplest and 
most accepted method to detect ventricular dyssynchrony is 12-lead electrocardiography 
(ECG). In general, CRT response is predicted based on the patient’s basic electrical 
dyssynchrony that can be improved by electrical manipulation. QRS duration and presence of 
left bundle branch block (LBBB) morphology on preprocedural ECG are strong predictors of 
CRT response.4)
Furthermore, many physicians have shown keen interest in predicting CRT response based 
on postprocedural ECG findings. However, shortening of QRS duration is not sufficient 
to accurately predict CRT response.5) Further, limited information is available regarding 
the application of other postprocedural ECG parameters reflecting complex LV electrical 
synchrony and its reversibility by electrical manipulation for predicting CRT response.
Recently, several studies have assessed the importance of different postprocedural ECG 
parameters for predicting CRT response. A study by Bode et al.6) showed that a positive vector 
in V1 and/or negative vector in lead I on postprocedural ECG, suggesting LV activation on the 
posterolateral capture from CRT, predicts CRT response. This effect was more prominent 
in patients without LBBB who benefited less from CRT than those with LBBB. Hence, 
identification of simple and novel ECG parameters, in addition to QRS duration or axis 
change, to predict CRT response seems crucial, but challenging.
The study by Jing et al.,7) in this issue of the Korean Circulation Journal, tried to investigate 
postprocedural ECG parameter other than QRS duration using QRS-T morphology 
screening (TMS), which was developed to identify patients who may be susceptible to T-wave 
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oversensing and has been used for subcutaneous implantable cardioverter defibrillator 
(S-ICD) prescreening to avoid inappropriate shocks. The authors enrolled 55 patients 
eligible for CRT implantation according to the current guidelines; all patients had LBBB 
morphology and did not pass TMS during preprocedural ECG. On the third day after CRT 
implantation, patients were classified into two groups depending on the postprocedural 
TMS results—those who passed at least one vector (TMS-passing group) and those who did 
not pass (non-passing group). Clinical variables, echocardiographic parameters, and other 
ECG parameters were analyzed before and after CRT implantation. After CRT implantation, 
39 (71%) patients passed TMS with biventricular pacing. Patients in the TMS-passing group 
showed a significantly higher clinical response rate to CRT than those in the non-passing 
group (80% vs. 31%), and TMS passing was found to be independently associated with 
CRT response. Among the overall study population, patients passing more than 2 vectors 
had a greater response (odds ratio [OR], 17.6; 95% confidence interval [CI], 2.4–131.6) and 
those passing only one vector also had a better response (OR, 8.1; 95% CI, 1.3–48.7) during 
follow-up when compared with non-passing patients. As expected, most super-responders 
belonged to the TMS-passing group and showed a linear relationship with the number of 
vectors passed. Corresponding to the CRT responder rate, change in left ventricular end-
systolic volume (LVESV) was significantly different between the TMS-passing group and the 
non-passing group (24% and 9% reduction, respectively). Other response parameters, such 
as the New York Heart Association class and left ventricular ejection fraction (LVEF), were not 
significantly different between the 2 groups.
The authors demonstrated that selected surface ECG measurement with TMS is a useful 
approach to predict CRT response and reflect whether LV pacing contributes to dyssynchrony 
correction and that adequate biventricular pacing is significant. TMS has been developed 
using ECG parameters including R-wave amplitude, T-wave amplitude, R/T ratio, QRS 
duration, and QT interval.8) Delayed activation of the LV lateral wall causes mechanical 
dysfunction, and LBBB morphology has been recognized as a potential indicator of delayed 
LV lateral wall activation, which is reflected by the QRS complex.9) Widening of the QRS 
duration and abnormal repolarization associated with ST-segment depression and T-wave 
inversion increases the probability of not passing TMS.10) On analyzing iterative optimization 
efforts in detail, it seems that adequate biventricular pacing through CRT improves 
mechanical dyssynchrony and abnormal repolarization caused by delayed activation of the 
left lateral wall and results in not only QRS complex normalization but also non-inverted 
T-wave. Although the results of this study are limited to patients with LBBB, understanding 
the electrophysiology of vectorcardiography and biventricular pacing aid in achieving better 
outcomes after CRT implantation. These results are consistent with those reported by 
previous studies, supporting the role of ECG information in the clinical follow-up of CRT and 
novel contribution of TMS.
However, there are some challenges. First, there are different values for defining CRT 
response, including LVESV, LVEF, and HF symptoms. Although the resolution of LVESV was 
different between the 2 groups, HF symptom improvement and LVEF were similar. It would 
be more logical if these values were considered. Second, while the authors focused on CRT 
response, information regarding clinical outcomes such as HF hospitalization, all-cause 
death, and implantable cardioverter defibrillator therapy for ventricular arrhythmias is 
lacking. Long-term follow-up data are needed to provide more helpful information. Third, 
the results of the present study cannot be adopted in patients without LBBB. Finally, it is 
unclear whether the application of TMS during the CRT procedure will help the operator 
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achieve more appropriate LV lead positioning. Further studies are warranted to determine the 
role of TMS in patients without LBBB, determine the clinical impact of TMS during CRT, and 
understand the ultimate association between TMS and electrical dyssynchrony.
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